Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
FATE THERAPEUTICS INC (FATE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/21/2023 |
4
| Dulac Edward J III (CFO) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 4,718 shares
@ $2.8, valued at
$13.2k
|
|
| 08/07/2023 |
4
| Xu Yuan (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 632 shares
@ $3.71, valued at
$2.3k
|
|
| 07/06/2023 |
4
| Powl Brian T. (Chief Commercial Officer) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 3,854 shares
@ $4.87, valued at
$18.8k
|
|
| 07/06/2023 |
4
| Dulac Edward J III (CFO) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 5,182 shares
@ $4.83, valued at
$25k
|
|
| 06/08/2023 |
4
| Redmile Group, LLC (10% Owner) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $5.52, valued at
$220.8k
|
|
| 06/08/2023 |
4
| Lee Michael Stewart (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $5.52, valued at
$220.8k
|
|
| 06/07/2023 |
4
| Xu Yuan (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $5.52, valued at
$220.8k
|
|
| 06/07/2023 |
4
| RASTETTER WILLIAM H (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $5.52, valued at
$220.8k
|
|
| 06/07/2023 |
4
| MENDLEIN JOHN (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $5.52, valued at
$220.8k
|
|
| 06/07/2023 |
4
| Jooss Karin (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $5.52, valued at
$220.8k
|
|
| 06/07/2023 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $5.52, valued at
$220.8k
|
|
| 06/07/2023 |
4
| EPSTEIN ROBERT S (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $5.52, valued at
$220.8k
|
|
| 06/07/2023 |
4
| COUGHLIN TIMOTHY (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $5.52, valued at
$220.8k
|
|
| 06/07/2023 |
4
| Agarwal Shefali (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $5.52, valued at
$220.8k
|
|
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2023 |
4
| Wolchko J Scott (President and CEO) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 500,000 options to buy
@ $6.77, valued at
$3.4M
|
|
| 02/07/2023 |
4
| Valamehr Bahram (Chief R&D Officer) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 450,000 options to buy
@ $6.77, valued at
$3M
|
|
| 02/07/2023 |
4
| TAHL CINDY (General Counsel and Secretary) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 425,000 options to buy
@ $6.77, valued at
$2.9M
|
|
| 02/07/2023 |
4
| Powl Brian T. (Chief Commercial Officer) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 425,000 options to buy
@ $6.77, valued at
$2.9M
|
|
| 02/07/2023 |
4
| Dulac Edward J III (CFO) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 425,000 options to buy
@ $6.77, valued at
$2.9M
|
|
| 02/07/2023 |
4
| Chu Yu-Waye (Chief Medical Officer) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 425,000 options to buy
@ $6.77, valued at
$2.9M
|
|
| 01/20/2023 |
4
| MENDLEIN JOHN (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Exercised 28,461 options to buy
@ $1.37, valued at
$39k
|
|
| 01/13/2023 |
4
| MENDLEIN JOHN (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Bought 88,048 shares
@ $5.67, valued at
$499.2k
Bought 36,631 shares
@ $5.43, valued at
$198.9k
|
|
| 01/13/2023 |
4
| Valamehr Bahram (Chief R&D Officer) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Exercised 423 options to buy
@ $1.37, valued at
$579.5 |
|
| 01/11/2023 |
4
| Wolchko J Scott (President and CEO) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 45,907 shares
@ $5.24, valued at
$240.6k
|
|
| 01/11/2023 |
4
| Valamehr Bahram (Chief R&D Officer) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 10,917 shares
@ $5.24, valued at
$57.2k
|
|
| 01/11/2023 |
4
| TAHL CINDY (General Counsel and Secretary) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 11,553 shares
@ $5.24, valued at
$60.5k
|
|
| 01/11/2023 |
4
| Plavsic Mark (Chief Technical Officer) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 3,418 shares
@ $5.24, valued at
$17.9k
|
|
| 01/11/2023 |
4
| Dulac Edward J III (CFO) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 7,331 shares
@ $5.24, valued at
$38.4k
|
|
| 01/11/2023 |
4
| Chu Yu-Waye (Chief Medical Officer) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 7,825 shares
@ $5.24, valued at
$41k
|
|
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2022 |
4
| Wolchko J Scott (President and CEO) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 10,829 shares
@ $32.54, valued at
$352.4k
Sold 19,171 shares
@ $33.07, valued at
$634k
Sold 2,923 shares
@ $31.33, valued at
$91.6k
Sold 2,703 shares
@ $32.61, valued at
$88.1k
Sold 620 shares
@ $33.28, valued at
$20.6k
Exercised 30,000 options to buy
@ $2.7, valued at
$81k
Exercised 6,246 options to buy
@ $2.7, valued at
$16.9k
|
|
|
|
|